Altaire Pharmaceuticals, Inc. Issues Voluntary Recall Of Multiple Ophthalmic Products Sold At Walgreens

AQUEBOGUE, N.Y., July 3, 2019 /PRNewswire/ -- Altaire Pharmaceuticals, Inc., announces today that it is voluntarily recalling the Over-the-Counter (OTC)  drug products and lots, within expiry, sold at Walgreens during the time period as indicated in the tables below.  As a precautionary measure, Altaire is initiating the recall due to management concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility.  This recall is being carried out to the retail level and is only for the specific lots listed above. No other lots are being recalled. 

Administration of a non-sterile product intended to be sterile may result in serious and potentially life threatening infections or death. To date, Altaire has received no reports of adverse events, nor has Altaire obtained any out of specifications  results  including Sterility testing, for the products.

Product Description: Lubricant Eye Drops  Moisturizing   Walgreens item #: 801483  NDC #: 0363-0185-13  Package Size: 15 mL

Product Description: Lubricant Eye Drops  Moisturizing Twin Pack Walgreens item #: 801477 NDC #: 0363-0185-49  Package Size: 2 x 15 mL

Product Description: Sodium Chloride Ophthalmic Ointment, 5% Hypertonicity  Eye Ointment  Walgreens item #: 801482   NDC #: 0363-7500-50  Package Size: 3.5 gram

Product Description: Sodium Chloride Ophthalmic Solution, 5% Hypertonicity Eye Drops   Walgreens item #: 801402   NDC #: 0363-0193-13  Package Size: 15 mL 

Product Description: Lubricant Eye Ointment PF Soothing  Walgreens item #: 801486  NDC #: 0363-0191-50  Package Size: 3.5 gram

The products are manufactured and labeled exclusively for Walgreens.  Altaire ships the products labeled for Walgreens only to Walgreens.  The products are distributed at the retail level by Walgreens.  Altaire has also requested that Walgreens  notify its customers.

Altaire has notified Walgreens by e-mail on July 3, 2019 announcing the recalls of the products/lots identified herein, with specific directions for return of all units of the impacted lots. 

Customers with questions regarding this recall can contact Altaire Pharmaceuticals Inc., by calling 1-800-258-2471, or e-mailing [email protected] Monday through Friday from 8:30 a.m. to 5:00 p.m. ET.  Customers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

• Online:www.fda.gov/medwatch/report.htm
• Regular Mail: use postage-paid, pre-addressed Form FDA 3500 available at: www.fda.gov/MedWatch/getforms.htm. Mail to address on the pre-addressed form.
• Fax: 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Altaire takes its mission of customer safety and providing quality products very seriously.  The company is committed to, and diligently working to, ensure the sufficiency of Quality Assurance controls over critical systems in its manufacturing facility. 

Company Contacts:
Michael Sawaya
Joseph Sawaya
1-800-258-2471

SOURCE Altaire Pharmaceuticals, Inc.

Related Links

http://www.fda.gov/MedWatch/report.htm